The pharmaceutical field is experiencing a major shift in diabetes therapy with the arrival of GLP-1 transdermal devices. These innovative delivery systems offer a possibly convenient alternative to needle injections for individuals dealing with diabetes mellitus type 2. By bypassing the necessity for frequent pokes, GLP-1 skin devices promise to i